These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2007290)

  • 61. Detection of activated platelets in urinary sediments by immunofluorescence using monoclonal antibody to human platelet GMP-140 in patients with IgA nephropathy.
    Tomino Y; Tsushima Y; Ohmuro H; Shimizu M; Kuramoto T; Shirato I; Koide H
    J Clin Lab Anal; 1993; 7(6):329-33. PubMed ID: 7506303
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum levels of interleukin-2 receptor and disease activity in patients with IgA nephropathy.
    Tomino Y; Ozaki T; Koide H; Takahashi M; Ito K
    J Clin Lab Anal; 1989; 3(6):355-9. PubMed ID: 2482345
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Interleukin-1 beta in patients with primary immunocomplex glomerulonephritis].
    Hrvacević R; Dimitrijević D; Spasić P; Colić M; Maksić Dj; Marić M
    Vojnosanit Pregl; 2001; 58(1):33-8. PubMed ID: 11419285
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Histologic factors associated with nephrotic-range proteinuria in recurrent IGA nephropathy.
    Jeong HJ; Hong SW; Kim YS; Kim SI; Kim MS; Choi KH; Lee HY; Han DS; Park K
    Transplant Proc; 2003 Feb; 35(1):291. PubMed ID: 12591405
    [No Abstract]   [Full Text] [Related]  

  • 65. Pathologic conditions associated with IgA mesangial nephropathy: preliminary results.
    Makdassy R; Beaufils M; Meyrier A; Mignon F; Moulonguet-Doleris L; Richet G
    Contrib Nephrol; 1984; 40():292-5. PubMed ID: 6499459
    [No Abstract]   [Full Text] [Related]  

  • 66. [Proposal for a new histological classification of IgA nephropathy in Japan and a preliminary report of the international clinico-pathological classification of IgA nephropathy].
    Joh K
    Nihon Jinzo Gakkai Shi; 2008; 50(4):448-55. PubMed ID: 18546873
    [No Abstract]   [Full Text] [Related]  

  • 67. Glomerular localization of interleukin-6 suppressed by steroid mini-pulse therapy in an IgA nephropathy patient.
    Taniguchi Y; Yorioka N; Oda H; Okushin S; Nishida Y; Yamakido M; Taguchi T
    Intern Med; 1995 Dec; 34(12):1181-5. PubMed ID: 8929646
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relationship between levels of urinary type IV collagen and renal injuries in patients with IgA nephropathy.
    Io H; Hamada C; Fukui M; Horikoshi S; Tomino Y
    J Clin Lab Anal; 2004; 18(1):14-8. PubMed ID: 14730552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Urinary interleukin-6 and interleukin-8 in females with urethral syndrome].
    Yasumoto R; Kawano M; Senju M; Nishisaka N; Kyo M; Kishimoto T
    Hinyokika Kiyo; 1997 Apr; 43(4):267-70. PubMed ID: 9161853
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography.
    Kalantari S; Rutishauser D; Samavat S; Nafar M; Mahmudieh L; Rezaei-Tavirani M; Zubarev RA
    PLoS One; 2013; 8(12):e80830. PubMed ID: 24339887
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study.
    Neprasova M; Maixnerova D; Novak J; Reily C; Julian BA; Boron J; Novotny P; Suchanek M; Tesar V; Kacer P
    Dis Markers; 2016; 2016():3650909. PubMed ID: 27799660
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IgA mesangial nephropathy in neoplastic diseases.
    Mustonen J; Pasternack A; Helin H
    Contrib Nephrol; 1984; 40():283-91. PubMed ID: 6499458
    [No Abstract]   [Full Text] [Related]  

  • 73. [Follow-up of two patients with mesangial IgA glomerulonephritis exposed to cadmium and organic solvents].
    Fernández J; Sanz-Gallén P; Nogué S
    An Sist Sanit Navar; 2010; 33(3):309-13. PubMed ID: 21233866
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term prognosis and prognostic factors of Japanese children with mesangial proliferative glomerulonephritis without IgA deposition.
    Kaku Y; Hisano S; Yamane I; Hatae K; Ueda K; Sueishi K
    Acta Paediatr Jpn; 1995 Aug; 37(4):458-63. PubMed ID: 7572145
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic indices and therapy in IgA nephropathy: toward a solution.
    Ballardie FW; Cowley RD
    Kidney Int; 2008 Feb; 73(3):249-51. PubMed ID: 18195693
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnostic urinary proteome profile for immunoglobulin a nephropathy.
    Samavat S; Kalantari S; Nafar M; Rutishauser D; Rezaei-Tavirani M; Parvin M; Zubarev RA
    Iran J Kidney Dis; 2015 May; 9(3):239-48. PubMed ID: 25957429
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Urinary IL-6: a marker for mesangial proliferative glomerulonephritis?
    Gordon C; Richards N; Howie AJ; Richardson K; Michael J; Adu D; Emery P
    Clin Exp Immunol; 1991 Oct; 86(1):145-9. PubMed ID: 1914227
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chromosomal telomere shortening of kidney cells in IgA nephropathy by the measurement of DNA in urinary sediment.
    Szeto CC; Poon PY; Lai FM; Chow KM; Szeto CY; Li PK
    Clin Nephrol; 2005 Nov; 64(5):337-42. PubMed ID: 16312260
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pathogenesis of IgA nephropathy in ethanol consumption: animal model and cell culture studies.
    Smith SM; Leaber R; Lefebre A; Leung MF; Baricos WH; Leung WC
    Alcohol; 1993; 10(6):477-80. PubMed ID: 8123203
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Candidate Urine Peptide Biomarkers for IgA Nephropathy: Where Are We Now?
    Marek-Bukowiec K; Konieczny A; Ratajczyk K; Witkiewicz W
    Dis Markers; 2018; 2018():5205831. PubMed ID: 29606986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.